Estella Matutes researcher
Matutes, Estella
VIAF ID: 48564884 (Personal)
Permalink: http://viaf.org/viaf/48564884
Preferred Forms
- 100 0 _ ‡a Estella Matutes ‡c researcher
- 100 1 _ ‡a Matutes, Estella
-
-
- 100 1 _ ‡a Matutes, Estella
- 100 1 _ ‡a Matutes, Estella
-
4xx's: Alternate Name Forms (1)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial | |
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study | |
The natural history and clinico-pathological features of the variant form of hairy cell leukemia. | |
The nature of T-chronic lymphocytic leukaemia | |
[Normal human neutrophilic granulocyte. An assesment of its enzyme activities related to phagocytosis | |
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease. | |
Novel and emerging drugs for rarer chronic lymphoid leukaemias | |
Oestrogen receptor | |
p53 abnormalities in B-cell prolymphocytic leukemia. | |
p53 gene deletion and trisomy 12 in hairy cell leukemia and its variant | |
Persistent polyclonal B-cell lymphocytosis | |
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL). | |
Phenotypic conversion of TdT+ adult AML to CALLA+ ALL. | |
[Physiological aspects of human neutrophilic granulocyte with special reference to chemotaxis and phagocytosis (author's transl)] | |
Polyclonal integration of HTLV-I proviral DNA in lymphocytes from HTLV-I seropositive individuals: an intermediate state between the healthy carrier state and smouldering ATL. | |
Predicting time to first treatment in early stage CLL: scores, values and comparative prognostic models. | |
Presence of adenosine deaminase on the surface of mononuclear blood cells: immunochemical localization using light and electron microscopy | |
Primary Bone Marrow Lymphoma | |
Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation | |
Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients | |
The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma | |
Proliferation in liquid culture of megakaryocytes from the blood of patients with primary myelofibrosis and other myeloproliferative disorders. | |
Prolonged treatment response in aggressive natural killer cell leukemia | |
[Prophylaxis of infections in granulocytopenic patients (author's transl] | |
Prospective study of HTLV-I infection in an initially asymptomatic cohort. | |
Purification of haemopoietic progenitor cells from patients with chronic granulocytic leukaemia using percoll density gradients and elutriation. | |
Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection | |
Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia | |
Relationship of T leukaemias with cerebriform nuclei to T-prolymphocytic leukaemia: a cytogenetic analysis with in situ hybridization | |
The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL). | |
Report of the second international symposium on HTLV in Brazil. | |
The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry | |
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia | |
The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukaemia | |
Royal Marsden teaching cases. An elderly man with weight loss and anaemia | |
Sezary cell-like leukemia: a distinct type of mature T cell malignancy | |
Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use. | |
Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features | |
Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations | |
Strongyloides stercoralis as candidate co-factor for HTLV-I-induced leukaemogenesis. | |
Studies in healthy human T-cell-leukemia lymphoma virus (HTLV-I) carriers from the Caribbean | |
[Studies on the human granulocyte motility. A method on agarose (author's transl)] | |
T-cell leukaemias with "helper" phenotype in adults | |
T-cell leukemias with rearrangement of the gamma but not beta T-cell receptor genes | |
T-cell lymphoproliferative disorders, c1999: | |
T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases. | |
Teaching cases from the Royal Marsden and St Mary's Hospitals case 25. A young boy with massive bilateral renal enlargement. | |
Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia | |
Transformation of T-cell large granular lymphocyte leukaemia into a high-grade large T-cell lymphoma | |
Translocation t(11;14)(q13;q32) in chronic lymphoid disorders | |
Translocations t(14;18) and t(8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3). | |
Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. | |
[Ultratructural aspects of the neutrophilic granulocyte in relation to its function | |
The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry | |
The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia | |
Very Low Seroprevalence of HTLV-I/II in Cuba: Antibodies in Blood Donors and in Hematological and Nonhematological Patients |